pc 버전으로 이동 중 [시장보고서]미생물 발효 기술 시장 규모, 점유율, 동향 분석 리포트 : 응용별(항생제, 백신), 최종 응용별(바이오 제약회사), 지역별, 부문별 예측(2022-2030년)
미생물 발효 기술 시장 규모, 점유율, 동향 분석 리포트 : 응용별(항생제, 백신), 최종 응용별(바이오 제약회사), 지역별, 부문별 예측(2022-2030년)
Microbial Fermentation Technology Market Size, Share & Trends Analysis Report By Application (Antibiotics, Vaccines), By End-use (Biopharmaceutical Companies), By Region, And Segment Forecasts, 2022 - 2030
상품코드 : 1147468
리서치사 : Grand View Research, Inc.
발행일 : 2022년 10월
페이지 정보 : 영문 170 Pages
US $ 5,950 ₩ 7,404,000
Unprintable PDF (Single User License)
US $ 6,950 ₩ 8,648,000
Printable PDF (5-User License)
US $ 8,950 ₩ 11,137,000
Printable PDF (Enterprise License)


한글목차

Grand View Research, Inc.의 최신 보고서에 따르면 미생물 발효 기술 세계 시장 규모는 2030년까지 494억 달러에 이를 것으로 예측됩니다. 이 시장은 2022년부터 2030년까지 연평균 복합 성장률(CAGR) 6.0%로 확대될 것으로 예측됩니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 변수, 동향 및 범위

제4장 미생물 발효 기술 시장 : 응용 비즈니스 분석

제5장 미생물 발효 기술 시장 : 최종사용자 비즈니스 분석

제6장 미생물 발효 기술 시장 : 지역 비즈니스 분석

제7장 기업 개요

LSH 22.11.17
영문 목차

영문목차

Microbial Fermentation Technology Market Growth & Trends:

The global microbial fermentation technology market size is expected to reach USD 49.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2022 to 2030. Since fermentation is observed to be of utmost importance in the manufacturing of biopharmaceuticals, there is also a growing demand for microbial fermentation technology in biopharmaceutical manufacturing. This has led to increasing collaborations and developments in this market space.

For instance, in September 2021, BIOVECTRA and ABEC collaboratively announced that the latter company would provide CSR single-use microbial fermentation solutions to expand BIOVECTRA's manufacturing capabilities. The newly installed solutions are expected to provide a faster turnaround time with high-growth microbial fermentation on large scale. Moreover, in September 2022, Cargill and Genomatica along with Cyclone Engineers are working on a project to scale up the bioreactor fermentation processing. This project is a part of the National Biotechnology and Biomanufacturing Initiative with a grant of USD 2.5 million.

Furthermore, technological advances in microbial fermentation platforms are also expected to supplement the market growth. For instance, several metabolic engineering approaches have been developed by researchers to enhance the performance of microbial cell factories used for the production of complex biologics or small molecules. Such continuous developments in this market space are likely to increase the adoption of this technology in biomanufacturing.

Additionally,various medications and vaccines, such as hormones, antibody fragments, and pneumococcal vaccines, are bio-manufactured using microbial fermentation techniques. Bacterial cells are often resistant to shear damage, enabling the use of high-shear radial impeller systems and high agitation rates. This gives the fermentors a high mass transfer potential, allowing them to accommodate fast metabolizing, high-cell density microbial cell cultivations and increasing the quantity of product that the bioprocesses can produce. Thus, with the increasing adoption of SUB fermentors for bacterial fermentation, the market is likely to witness significant growth in the coming years.

Microbial Fermentation Technology Market Report Highlights:

Table of Contents

Chapter 1 Methodology And Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends, & Scope

Chapter 4 Microbial Fermentation Technology Market: Application Business Analysis

Chapter 5 Microbial Fermentation Technology Market: End-User Business Analysis

Chapter 6 Microbial Fermentation Technology Market: Regional Business Analysis

Chapter 7 Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기